Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Cash | 0.61 | 0.80 | 11.07 | 3.84 |
Cash Equivalents | 0.89 | 1.59 | 6.15 | 0.56 |
Cashand Short Term Investments | 1.50 | 2.39 | 17.22 | 4.40 |
Accounts Receivable- Trade Net | 3.59 | 2.48 | 18.56 | 14.77 |
Total Receivables Net | 3.59 | 7.05 | 20.96 | 14.82 |
Total Inventory | 19.04 | 29.65 | 27.84 | 17.26 |
Other Current Assets Total | 13.76 | 0.12 | 0.19 | 27.85 |
Total Current Assets | 37.89 | 39.22 | 66.30 | 64.32 |
Property/ Plant/ Equipment Total- Net | 86.33 | 92.78 | 125.09 | 137.51 |
Intangibles Net | 25.94 | 30.82 | 16.76 | 5.45 |
Long Term Investments | 0.00 | 0.39 | 0.38 | - |
Other Long Term Assets Total | 0.71 | 0.64 | 0.00 | 0.00 |
Total Assets | 150.87 | 163.86 | 209.17 | 207.86 |
Accounts Payable | 14.05 | 9.43 | 16.91 | 12.72 |
Current Portof LT Debt/ Capital Leases | 22.08 | 21.77 | 20.17 | 0.00 |
Other Currentliabilities Total | 12.74 | 10.83 | 6.86 | 27.81 |
Total Current Liabilities | 48.87 | 42.73 | 44.75 | 40.54 |
Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
Total Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
Total Debt | 22.08 | 21.77 | 20.17 | 0.00 |
Deferred Income Tax | 4.85 | 2.24 | 5.91 | 7.82 |
Other Liabilities Total | 0.47 | 0.61 | 0.63 | 0.59 |
Total Liabilities | 54.19 | 45.57 | 51.29 | 48.94 |
Common Stock Total | 50.10 | 50.10 | 50.10 | 40.67 |
Retained Earnings( Accumulated Deficit) | 46.58 | 26.21 | 65.81 | 118.24 |
Other Equity Total | 0.00 | 0.00 | 0.00 | - |
Total Equity | 96.68 | 118.29 | 157.88 | 158.92 |
Total Liabilities Shareholders' Equity | 150.87 | 163.86 | 209.17 | 207.86 |
Total Common Shares Outstanding | 5.01 | 5.01 | 5.01 | 4.07 |
Tangible Book Valueper Share Common Eq | 14.12 | 17.46 | 28.17 | 37.73 |
Prepaid Expenses | - | 0.01 | 0.09 | - |
Property/ Plant/ Equipment Total- Gross | - | 199.32 | 219.82 | - |
Accumulated Depreciation Total | - | -106.54 | -94.72 | - |
Accrued Expenses | - | 0.70 | 0.81 | - |
Notes Payable/ Short Term Debt | - | 0.00 | 0.00 | 0.00 |
Additional Paid- In Capital | - | 41.98 | 41.98 | - |
Note Receivable- Long Term | - | - | 0.63 | 0.59 |
Lasa Supergenerics Dividend Lasa Supergenerics Bonus Lasa Supergenerics News Lasa Supergenerics AGM Lasa Supergenerics Rights Lasa Supergenerics Splits Lasa Supergenerics Board Meetings Lasa Supergenerics Key Metrics Lasa Supergenerics Shareholdings Lasa Supergenerics Profit Loss Lasa Supergenerics Cashflow Lasa Supergenerics Q1 Results Lasa Supergenerics Q2 Results Lasa Supergenerics Q3 Results Lasa Supergenerics Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks